Literature DB >> 6193933

Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis.

R H Resnick, K Stone, D Antonioli.   

Abstract

In 1964 a 42-year-old woman was hospitalized with clinical and laboratory signs of posttransfusion hepatitis five weeks after administration of six whole blood transfusions. During the following 17 years anicteric chronic liver disease was repeatedly documented by elevations of serum aspartate aminotransferase (SGOT) and alkaline phosphatase enzymes. In 1981 hepatomegaly, progressive jaundice, and a serum alphafetoprotein level of 516,000 ng/ml were observed. Percutaneous liver biopsy showed a primary hepatocellular carcinoma (PHC). Serologic examinations failed to reveal markers for hepatitis B virus including HBsAg, anti-HBs, and anti-HBc by radioimmunoassay; antibody to hepatitis A virus was also absent. This sequence of events demonstrates a presumptive association of PHC and the agent(s) of non-A, non-B viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193933     DOI: 10.1007/bf01317042

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Natural history of hepatitis-associated antigen-positive chronic liver disease.

Authors:  F J Dudley; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

2.  Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa.

Authors:  M C Kew
Journal:  Hepatology       Date:  1981 Jul-Aug       Impact factor: 17.425

3.  Hepatitis B virus and hepatocellular carcinoma: molecular biology provides further evidence for an etiologic association.

Authors:  A M Prince
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

4.  Hepatitis B virus and the prevention of primary hepatocellular carcinoma.

Authors:  B S Blumberg; W T London
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

5.  Chronic non-A, non-B hepatitis carrier state: transmissible agent documented in one patient over a six-year period.

Authors:  E Tabor; L B Seeff; R J Gerety
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

6.  Three recently described animal virus models for human hepatitis B virus.

Authors:  J Summers
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

7.  Absence of an association between past infection with hepatitis A virus and primary hepatocellular carcinoma.

Authors:  E Tabor; D Trichopoulos; O Manousos; X Zavitsanos; J A Drucker; R J Gerety
Journal:  Int J Epidemiol       Date:  1980-09       Impact factor: 7.196

8.  Faecal shedding of hepatitis-A antigen.

Authors:  J L Dienstag; S M Feinstone; A Z Kapikian; R H Purcell
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

9.  Transmissible agent in non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; P V Holland; H Popper
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

10.  Transmission of non-A, non-B hepatitis from man to chimpanzee.

Authors:  E Tabor; R J Gerety; J A Drucker; L B Seeff; J H Hoofnagle; D R Jackson; M April; L F Barker; G Pineda-Tamondong
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

View more
  15 in total

Review 1.  Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan.

Authors:  K Kiyosawa; S Furuta
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Primary hepatocellular carcinoma following nonspecific non-B hepatitis with tumor DNA negative for HBV DNA.

Authors:  E B Cohen; D L Gang; J B Zeldis
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

3.  Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.

Authors:  T Miyamura; I Saito; T Katayama; S Kikuchi; A Tateda; M Houghton; Q L Choo; G Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 4.  Hepatitis C virus and transfusion transmitted liver disease: review.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

Review 5.  Patterns of progression: unpredictability and risk of decompensated cirrhosis.

Authors:  N C Tassopoulos
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 6.  Chronic viral diseases.

Authors:  B Berris
Journal:  CMAJ       Date:  1986-12-01       Impact factor: 8.262

Review 7.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

8.  [Hepatitis non-A, non-B: epidemiologic, clinical, serologic and morphologic aspects].

Authors:  H P Spichtin
Journal:  Klin Wochenschr       Date:  1985-05-02

9.  A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier.

Authors:  S Ohkoshi; H Tawaraya; K Kuwana; T Harada; M Watanabe; S Higuchi; H Kojima; T Kamimura; H Asakura
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

10.  Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.

Authors:  J Bukh; R H Miller; M C Kew; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.